A Human FAAH Variant Was Modeled in Mice, With a Selective Alcohol-Intake Finding

A mouse carrying a human-associated FAAH variant can test a biological hypothesis, but its drinking behavior is not a genetic prediction for an individual person. A review describes increased binge-like alcohol intake alongside unchanged intake of sweet solutions in this model.

The variant affected an endocannabinoid enzyme

Kunos’s 2020 review discusses the FAAH C385A variant, associated with reduced FAAH expression in human peripheral tissues and reports of problem drug use. FAAH contributes to the breakdown of anandamide.

A knock-in mouse carrying the corresponding variant showed reduced FAAH expression and activity. This experimental step helped connect a genetic change with altered enzyme function rather than relying only on an association between genotype and behavior.

The behavioral comparison had useful controls

Mice carrying the variant had higher binge-like alcohol intake than the comparison genotype, without a corresponding difference in saccharin or sucrose intake. A CB1 antagonist inhibited alcohol intake in a dose-dependent manner.

The sweet-solution controls support selectivity within the tested drinking procedure. The antagonist result supports CB1 involvement. Neither finding establishes that the genotype determines every reward-related behavior or that FAAH is the only relevant pathway.

A mechanistic model is not a personal risk score

The human observations and the controlled mouse experiment are different evidence types. A human association does not independently establish causation, while a mouse manipulation cannot quantify a person’s probability of developing alcohol use disorder.

The study’s value lies in testing a possible enzyme–receptor–behavior connection. Applying that result to clinical prediction would require evidence about human populations, performance of the prediction and factors beyond the single variant. It does not establish a cannabis-exposure or impairment test.

Related reading: Increased Endocannabinoid Formation Can Coexist With Reduced Receptor Responsiveness in Alcohol Research.

Research cited

Kunos G. Interactions Between Alcohol and the Endocannabinoid System (2020). This analysis draws on the review’s discussion of the cited experiments.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Four-Day Session Washout Was Not Four Days of Cannabis Abstinence

The interval between experimental sessions should not be mistaken for verified cannabis abstinence. In a heavy-user study, participants could continue their usual cannabis routine despite a minimum four-day interval between treatments. The instructions defined the exposure history Ramaekers and colleagues allowed usual cannabis smoking during the study period. Participants were…

Spread the love

Read Article: A Four-Day Session Washout Was Not Four Days of Cannabis Abstinence

Booster Alcohol Doses Changed What a Cannabis Cross-Tolerance Study Tested

Maintaining alcohol concentrations with repeated booster doses tests a different exposure pattern from a single drink followed by falling concentrations. That difference mattered in a study of heavy cannabis users. The protocol aimed to sustain exposure Ramaekers and colleagues targeted steady alcohol concentrations across several hours, using booster doses as…

Spread the love

Read Article: Booster Alcohol Doses Changed What a Cannabis Cross-Tolerance Study Tested

The Primate THC Study Did Not Directly Measure Drug Metabolism as a Tolerance Mechanism

A behavioral pattern consistent with receptor adaptation does not independently rule out pharmacokinetic contributions. A primate study explicitly states that drug metabolism and disposition were not assessed. The behavioral comparison supported a receptor hypothesis McMahon found different degrees of tolerance and cross-tolerance among THC and synthetic cannabinoid agonists. The pattern…

Spread the love

Read Article: The Primate THC Study Did Not Directly Measure Drug Metabolism as a Tolerance Mechanism

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us